On the public citation graph

Pharmacogenomics: a key component of personalized therapy

0 signed · 49 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.cell.2012.02.009openalex-snapshot
Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes
inferredcites →https://doi.org/10.1038/clpt.2010.260openalex-snapshot
The Emerging Role of Electronic Medical Records in Pharmacogenomics
inferredcites →https://doi.org/10.1038/clpt.2011.185openalex-snapshot
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
inferredcites →https://doi.org/10.1038/sj.tpj.6500361openalex-snapshot
Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine
inferredcites →https://doi.org/10.1056/nejmp1203102openalex-snapshot
Escaping the EHR Trap — The Future of Health IT
inferredcites →https://doi.org/10.1074/jbc.m112.393637openalex-snapshot
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner
inferredcites →https://doi.org/10.1146/annurev-pharmtox-010510-100502openalex-snapshot
Omics and Drug Response
inferredcites →https://doi.org/10.1182/blood-2011-07-367763openalex-snapshot
Warfarin pharmacogenetics meets clinical use
inferredcites →https://doi.org/10.1200/jco.2012.44.6625openalex-snapshot
Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/9781118705308.ch10openalex-snapshot
Multidrug Resistance Proteins of the ABCC Subfamily
inferred← citeshttps://doi.org/10.1007/10_2019_110openalex-snapshot
The Impact of Pharmacogenomics in Personalized Medicine
inferred← citeshttps://doi.org/10.1007/978-3-031-51089-2_1openalex-snapshot
Introduction to Drug Safety and Pharmacovigilance
inferred← citeshttps://doi.org/10.1007/978-3-031-76718-0_3openalex-snapshot
A Brief Introduction to Pharmacogenomics and Personalized Medicine in the Drug Design Context
inferred← citeshttps://doi.org/10.1007/978-3-319-39349-0_14openalex-snapshot
Personalized Medicine in Clinical Pharmacology
inferred← citeshttps://doi.org/10.1007/978-3-319-66224-4_17openalex-snapshot
Platelets and Polymorphisms
inferred← citeshttps://doi.org/10.1007/978-3-319-67092-8_29openalex-snapshot
Post-modern Medicolegal and Forensic Toxicology
inferred← citeshttps://doi.org/10.1007/s11096-024-01709-xopenalex-snapshot
Unveiling the future: precision pharmacovigilance in the era of personalized medicine
inferred← citeshttps://doi.org/10.1007/s13311-014-0262-5openalex-snapshot
Genetic Biomarkers in Epilepsy
inferred← citeshttps://doi.org/10.1016/b978-0-12-809967-4.00013-2openalex-snapshot
Pharmacogenetics
inferred← citeshttps://doi.org/10.1016/b978-0-12-819541-3.00022-0openalex-snapshot
Personalized biomedicine in cancer: from traditional therapy to sustainable healthcare
inferred← citeshttps://doi.org/10.1016/b978-0-323-95120-3.00004-xopenalex-snapshot
Role of pharmacogenomics for prediction of personalized medicines
inferred← citeshttps://doi.org/10.1016/b978-0-323-95502-7.00279-7openalex-snapshot
Big Data Analysis in Personalized Medicine
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.114784openalex-snapshot
Integrative toxicogenomics: Advancing precision medicine and toxicology through artificial intelligence and OMICs technology
inferred← citeshttps://doi.org/10.1016/j.drudis.2013.06.003openalex-snapshot
Genomics and transcriptomics in drug discovery
inferred← citeshttps://doi.org/10.1016/j.ijpx.2026.100526openalex-snapshot
A decade of innovation in healthcare: Automation, bio-printing and digital twin technologies for personalized therapies
inferred← citeshttps://doi.org/10.1038/tpj.2013.24openalex-snapshot
Pharmacogenomics, ancestry and clinical decision making for global populations
inferred← citeshttps://doi.org/10.1080/17512433.2020.1702877openalex-snapshot
Steroid-resistant nephrotic syndrome: pharmacogenetics and epigenetic points and views
inferred← citeshttps://doi.org/10.1089/omi.2013.0055openalex-snapshot
Tamoxifen Integromics and Personalized Medicine: Dynamic Modular Transformations Underpinning Response to Tamoxifen in Breast Cancer Treatment
inferred← citeshttps://doi.org/10.1093/bib/bbv094openalex-snapshot
Updates on drug–target network; facilitating polypharmacology and data integration by growth of DrugBank database
inferred← citeshttps://doi.org/10.1093/jpp/rgag001openalex-snapshot
Precision pharmaceutics: bioinformatics and pharmacogenomics as catalysts for personalized drug therapy
inferred← citeshttps://doi.org/10.1097/ftd.0000000000000525openalex-snapshot
Mass Spectrometry for Research and Application in Therapeutic Drug Monitoring or Clinical and Forensic Toxicology
inferred← citeshttps://doi.org/10.1101/2024.09.24.614782openalex-snapshot
MedGraphNet : Leveraging Multi-Relational Graph Neural Networks and Text Knowledge for Biomedical Predictions
inferred← citeshttps://doi.org/10.1109/i-pact44901.2019.8960113openalex-snapshot
DNA repair mutation detection using Deep learning strategy – A pharmacogenomic perspective
inferred← citeshttps://doi.org/10.1111/bph.13895openalex-snapshot
Drug repurposing screens and synergistic drug‐combinations for infectious diseases
inferred← citeshttps://doi.org/10.1111/joim.12330openalex-snapshot
Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
inferred← citeshttps://doi.org/10.1124/pharmrev.124.001049openalex-snapshot
Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes
inferred← citeshttps://doi.org/10.1186/gm414openalex-snapshot
2012 highlights in translational 'omics
inferred← citeshttps://doi.org/10.1186/s40168-024-01971-1openalex-snapshot
Host-specific effects of Eubacterium species on Rg3-mediated modulation of osteosarcopenia in a genetically diverse mouse population
inferred← citeshttps://doi.org/10.1371/journal.pone.0093769openalex-snapshot
An Ontology-Based, Mobile-Optimized System for Pharmacogenomic Decision Support at the Point-of-Care
inferred← citeshttps://doi.org/10.1517/21678707.2014.974554openalex-snapshot
The impact of integrated omics technologies for patients with rare diseases
inferred← citeshttps://doi.org/10.15406/mojcsr.2015.02.00032openalex-snapshot
Personalized Treatment: The Future of Medicine. A Perspective on the Preconditioning for Stem Cell Transplantation
inferred← citeshttps://doi.org/10.18632/oncotarget.27027openalex-snapshot
The landscape of novel and complementary targets for immunotherapy: an analysis of gene expression in the tumor microenvironment
inferred← citeshttps://doi.org/10.2174/1871530319666190228102212openalex-snapshot
The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects
inferred← citeshttps://doi.org/10.2217/pgs.13.142openalex-snapshot
Multiomics Medicine in Oncology: Assessing Effectiveness, Cost–effectiveness and Future Research Priorities for the Molecularly Unique Individual
inferred← citeshttps://doi.org/10.3109/1354750x.2015.1068859openalex-snapshot
Genetic polymorphism of pharmacogenomic VIP variants in the Deng people from the Himalayas in Southeast Tibet
inferred← citeshttps://doi.org/10.3390/genes15040521openalex-snapshot
Contradiction in Star-Allele Nomenclature of Pharmacogenes between Common Haplotypes and Rare Variants
inferred← citeshttps://doi.org/10.3390/nu16132023openalex-snapshot
Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study
inferred← citeshttps://doi.org/10.3390/ph17070940openalex-snapshot
Pharmacogenomics: A Genetic Approach to Drug Development and Therapy
inferred← citeshttps://doi.org/10.7759/cureus.71896openalex-snapshot
Frequency Distributions of Alleles and Genotypes and Lung Cancer Risk of Polymorphisms DCK, SLC29A1, and SLC29A3 in South Indian Healthy Population
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.